Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
Lalezari JP, Beal JA, Ruane PJ, Cohen CJ, Jacobson EL, Sundin D, Leong WP, Raffanti SP, Wheeler DA, Anderson RD, Keiser P, Schrader SR, Goodgame JC, Steinhart CR, Murphy RL, Wolin MJ, Smith KA.
Lalezari JP, et al. Among authors: ruane pj.
HIV Clin Trials. 2000 Nov-Dec;1(3):1-15. doi: 10.1310/T5FR-8JPX-0NEF-XDKD.
HIV Clin Trials. 2000.
PMID: 11590500
Clinical Trial.